z-logo
open-access-imgOpen Access
Temporal trends in prognosis of patients with acute coronary syndrome complicated by ventricular tachyarrhythmia
Author(s) -
Yahud Ella,
LaishFarkash Avishag,
Shlomo Nir,
Fink Noam,
Goldenberg Ilan,
Lev Eli,
Asher Elad
Publication year - 2021
Publication title -
international journal of clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.756
H-Index - 98
eISSN - 1742-1241
pISSN - 1368-5031
DOI - 10.1111/ijcp.14623
Subject(s) - medicine , acute coronary syndrome , incidence (geometry) , cardiology , mortality rate , pediatrics , myocardial infarction , physics , optics
Objectives To evaluate clinical characteristics and prognosis of patients presented with acute coronary syndrome (ACS) that developed ventricular tachyarrhythmia VTA and to analyse it according to the period of presentation. Background VTA is an infrequent yet serious complication of ACS. There is limited data regarding the incidence and prognostic implications of VTA in the last decade as compared with the previous decade. Methods We evaluated clinical characteristics, major adverse cardiovascular events, short and long‐ term mortality of patients hospitalised with ACS who were enrolled in the Acute Coronary Syndrome Israeli Survey (ACSIS) during the years 2000‐2016. Patients were classified into three groups: no VTA, early VTA (≤48 hours of onset) and late VTA (>48 hours of onset). Data were analysed according to the period of presentation: early vs late period (years 2000‐2006 and 2008‐2016 accordingly). Results The study population comprised 15,200 patients. VTA occurred in 487 (3.2%) patients. Early VTA presented in 373/487 (77%) patients and late VTA in 114/487 (23%) patients. VTA’s, occurring in ACS patients were associated with increased risk of in‐hospital, 30‐days, 1‐year and 5‐year mortality rates during both early and late periods compared with no VTA. Moreover, late VTA was associated with the highest mortality rate with up to 65% in 5‐year follow up ( P  < .001). Nevertheless, late VTA was associated with a lower mortality rate in the late period compared with the early period. Conclusions Any VTA following ACS was associated with high short‐ and long‐term mortality rate. However, over the late period, there has been a significant improvement in survival rates, especially in patients with late VTA. This may be attributed to early and invasive reperfusion therapy, implantable cardioverter‐defibrillator implantation and better medical treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom